Cancer News and Research

Latest Cancer News and Research

Protein activated by inflammation converts glioblastoma multiforme cells to most aggressive form

A prominent protein activated by inflammation is the key instigator that converts glioblastoma multiforme cells to their most aggressive, untreatable form and promotes resistance to radiation therapy, an international team lead by researchers at The University of Texas MD Anderson Cancer Center reported online today in the journal Cancer Cell.

30 Aug 2013

New joint research effort examines unique manifestation of breast cancer in Kenya

Breast cancer is a major health problem worldwide and the incidence of the disease is rising across Africa. A new joint research effort between the University of Notre Dame's Eck Institute for Global Health and Harper Cancer Research Institute and a Kenyan doctoral student from Moi University is examining the unique manifestation of breast cancer in Kenya.

30 Aug 2013

Absence or presence of single protein can make cancer cells more or less susceptible to drugs

A new weakness has been discovered in cancer cells that may make them more susceptible to chemotherapy and other treatments. In a research report appearing in the September 2013 issue of The FASEB Journal, scientists identify the HDAC5 protein as being essential for the maintenance of structures, called telomeres, within cancer cells that promote cancer cells longevity.

30 Aug 2013

Researchers discover protein that may help predict breast cancer prognosis

Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology.

30 Aug 2013

Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC

Albumin-bound paclitaxel plus carboplatin is an effective and well-tolerated first-line treatment in patients with advanced non-small-cell lung cancer, irrespective of histology, study results show.

29 Aug 2013

First Edition: August 29, 2013

Today's headlines include reports about ongoing fiscal fights surrounding efforts to raise the nation's debt limit and to defund the health law. Also, the White House enlists former President Bill Clinton to help spread the word about the overhaul.

29 Aug 2013

Researchers discover old cancer drug can be used to prevent rejection of transplanted tissue

Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments for both transplant patients and patients with autoimmune diseases.

29 Aug 2013

FDA approves NDA filing for ibrutinib inhibitor in two B-cell malignancies

Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, for two B-cell malignancy indications: previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

29 Aug 2013

Many men find prostate cancer treatment as a big challenge

After fighting off prostate cancer and beginning the road to recovery, many men are finding the expense of cancer treatment is almost as big a challenge as the disease.

29 Aug 2013

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).

29 Aug 2013

UTHealth professors receives 2013 Distinguished Investigator Award of Academy of Radiology Research

Ponnada Narayana, Ph.D., and Jonathan Ophir, Ph.D., professors in the Department of Diagnostic and Interventional Imaging at The University of Texas Health Science Center at Houston (UTHealth) Medical School, are among recipients of the 2013 Distinguished Investigator Award of the Academy of Radiology Research.

29 Aug 2013

Biostatistician uses statistical and computer modeling for policy development in prostate cancer research

Ruth Etzioni, Ph.D., a biostatistician, is a member of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center.

29 Aug 2013

Fast food TV commercials aimed at children did not comply with self-imposed guidelines

Fast food TV commercials aimed at children 2-11 years old did not comply with self-imposed guidelines organized through the Better Business Bureau (BBB) during a one-year study period, according to Dartmouth researchers who published their findings today with PLOS ONE.

29 Aug 2013

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed - a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

29 Aug 2013

Experts share tips on preventing ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women. Approximately 22,000 women are diagnosed annually and 14,000 die from the disease. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

29 Aug 2013

NAMS publishes new guidance for diagnosing and treating vulvovaginal atrophy

Symptoms of vulvovaginal atrophy (VVA), such as lack of lubrication, irritated tissues, painful urination, and pain with intercourse, affect as many as 45% of women after menopause.

29 Aug 2013

Patient-relevant benefit of PET or PET/CT in oesophageal cancer is still unclear

The patient-relevant benefit of positron emission tomography (PET) in oesophageal cancer, alone or in combination with computed tomography (CT), is not proven due to a lack of comparative studies. In terms of their diagnostic and prognostic accuracy, it also remains unclear whether these diagnostic techniques can detect the spreading of tumours better than conventional diagnostics.

29 Aug 2013

AATS agrees with USPSTF recommendation for lung cancer screening of asymptomatic smokers

The American Association for Thoracic Surgery, a professional organization of surgeons dedicated to the diagnosis, treatment, and cure of diseases of the chest, strongly supports the United States Preventive Services Task Force draft recommendation for lung cancer screening of asymptomatic smokers.

29 Aug 2013

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

While it might be nice to pop a pill to protect your skin from the sun, a Loyola University Health System dermatologist warns that oral sunscreens are not as effective as traditional lotions and creams.

29 Aug 2013

Jia Shen receives 2013 Jess Hay Chancellor's Graduate Student Research Fellowship

Jia Shen, a student at The University of Texas Graduate School of Biomedical Sciences at Houston, is a recipient of a 2013 Jess Hay Chancellor's Graduate Student Research Fellowship. This award is given to two students per year across the entire University of Texas System, which is comprised of nine universities and six health institutions.

29 Aug 2013

Cancer News and Research

Latest Cancer News and Research

Protein activated by inflammation converts glioblastoma multiforme cells to most aggressive form

New joint research effort examines unique manifestation of breast cancer in Kenya

Absence or presence of single protein can make cancer cells more or less susceptible to drugs

Researchers discover protein that may help predict breast cancer prognosis

Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC

First Edition: August 29, 2013

Researchers discover old cancer drug can be used to prevent rejection of transplanted tissue

FDA approves NDA filing for ibrutinib inhibitor in two B-cell malignancies

Many men find prostate cancer treatment as a big challenge

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

UTHealth professors receives 2013 Distinguished Investigator Award of Academy of Radiology Research

Biostatistician uses statistical and computer modeling for policy development in prostate cancer research

Fast food TV commercials aimed at children did not comply with self-imposed guidelines

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

Experts share tips on preventing ovarian cancer

NAMS publishes new guidance for diagnosing and treating vulvovaginal atrophy

Patient-relevant benefit of PET or PET/CT in oesophageal cancer is still unclear

AATS agrees with USPSTF recommendation for lung cancer screening of asymptomatic smokers

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

Jia Shen receives 2013 Jess Hay Chancellor's Graduate Student Research Fellowship

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in